In conclusion, S100A9 is capable of binding to certain receptors, including TLR4, RAGE, and MCAM, through which it can trigger specific pathways which can then stimulate cancer cell proliferation, metastases, and malignancy. This evidence concerns the gene TLR4 and cancer.